| Name |
Salofalk 500 mg granule s produljenim oslobađanjem |
| Former Name |
Salofalk 500 mg želučanootporne granule s produljenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-842627661 |
| Active Substance |
mesalazin |
| Composition |
1 vrećica granula sadrži 500 mg mesalazina |
| Pharmaceutical Form |
Granule s produljenim oslobađanjem |
| Manufacturer |
Dr. Falk Pharma GmbH, Freiburg, Njemačka |
| Marketing Authorisation Holder |
Dr. Falk Pharma GmbH, Leinenweberstraße 5, Freiburg, Njemačka |
| Marketing Authorisation Date |
15.01.2021 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/16-02/516 |
| Registration Number |
381-12-01/70-21-28 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
A07EC02 |
| Marketing status |
stavljeno u promet |
| Shortage status |
u tijeku |
| SmPC |
download |
| PL |
download |
